Medical Marijuana Update

Medical Marijuana Update

Medical Marijuana Update

This was a quiet week on the medical marijuana front, but a couple of important changes happened on 1 July.

Hawaii  On Tuesday, a new report said dispensaries will generate millions for the state. The Aloha State finally got around to allowing dispensaries to operate this year, and now a report from the Hawaii Dispensary Alliance says they could generate between $12 million and $38 million in revenues in their 1st year in operation. That figure could grow to as much as $80 million by 2018, the group said, citing an anticipated increase in patient numbers.


As of last Friday, chronic pain patients qualify for medical marijuana. As of 1 July, intractable chronic pain that can’t be controlled with existing treatments is approved for medical marijuana use. The state Department of Health added intractable pain to the list of qualifying conditions effective today, the 1-year anniversary of the beginning of medical marijuana availability in the state.


As of last Friday, the medical marijuana system has been folded into the state’s adult sales system. As of 1 July, medical and recreational cannabis sales are combined, and only shops that have sought a special license can advise patients on medical use. All dispensaries that are not licensed under the new scheme were to shut down by Midnight 30 June. Only patients registered with the state will be able to avoid paying sales tax on their cannabis purchases.

For extensive information about this debate, presented in a neutral format, visit

By Phillip Smith

Paul Ebeling, Editor

Permission to Reprint: This article is licensed under a modified Creative Commons Attribution license.

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :